Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on August 12, 2026

Aug. 12, 2026

SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray

Indeterminate GlobeNewswire

Aug. 12, 2026

Tvardi Therapeutics to Host KOL Webinar on the Clinical Potential of TTI-109 in Ulcerative Colitis (UC) and the Evolving Treatment Landscape, on August 19, 2026

Indeterminate GlobeNewswire

Aug. 12, 2026

MUHC Foundation President and CEO Marie-Hélène Laramée appointed to Women’s Health Collective Canada Board of Directors

Indeterminate GlobeNewswire

Aug. 12, 2026

Marie-Hélène Laramée, présidente-directrice générale de la Fondation du CUSM, nommée au conseil d’administration de l’Association canadienne pour l’équité en santé des femmes

Indeterminate GlobeNewswire

Aug. 12, 2026

Solana Company to Release Second Quarter 2026 Operating Results on August 14, 2026

Indeterminate GlobeNewswire

Aug. 12, 2026

Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1

Indeterminate GlobeNewswire

Aug. 12, 2026

Reflect Scientific Reports More Than $1.4 Million in Freezer-System Sales to Biopharmaceutical Customers

Indeterminate GlobeNewswire

Aug. 12, 2026

NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma

Indeterminate GlobeNewswire

Aug. 12, 2026

Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors

Indeterminate GlobeNewswire

Aug. 12, 2026

ADARx Pharmaceuticals Expands Leadership Team with Board and Executive Appointments

Indeterminate GlobeNewswire

Aug. 12, 2026

Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Aug. 12, 2026

Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Aug. 12, 2026

PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 12, 2026

Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Aug. 12, 2026

Altimmune Announces Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Indeterminate GlobeNewswire

Aug. 12, 2026

BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

Aug. 12, 2026

Novonesis launches Optiva® Triticum to help pasta manufacturers navigate wheat volatility without compromising quality

Indeterminate GlobeNewswire

Aug. 12, 2026

Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire